U.S. markets open in 1 hour 22 minutes
  • S&P Futures

    4,463.75
    -10.50 (-0.23%)
     
  • Dow Futures

    34,695.00
    -54.00 (-0.16%)
     
  • Nasdaq Futures

    15,490.75
    -27.00 (-0.17%)
     
  • Russell 2000 Futures

    2,219.80
    -8.10 (-0.36%)
     
  • Crude Oil

    72.28
    -0.33 (-0.45%)
     
  • Gold

    1,759.60
    +2.90 (+0.17%)
     
  • Silver

    22.98
    +0.18 (+0.79%)
     
  • EUR/USD

    1.1787
    +0.0015 (+0.13%)
     
  • 10-Yr Bond

    1.3310
    0.0000 (0.00%)
     
  • Vix

    19.18
    +1.00 (+5.50%)
     
  • GBP/USD

    1.3797
    +0.0001 (+0.01%)
     
  • USD/JPY

    110.0230
    +0.3050 (+0.28%)
     
  • BTC-USD

    47,312.71
    -663.02 (-1.38%)
     
  • CMC Crypto 200

    1,198.31
    -34.98 (-2.84%)
     
  • FTSE 100

    7,022.05
    -5.43 (-0.08%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     

Pfizer cites 'totality' of clinical data in bid for COVID-19 booster approval

·1 min read
Pfizer cites 'totality' of clinical data in bid for COVID-19 booster approval
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Pfizer Inc. gained 0.1% in premarket trading on Wednesday after the drug maker said the "totality" of clinical data indicates that people who are at least 16 years old and were vaccinated with the COVID-19 shot that it developed with BioNTech SE should get a booster after six months. In a